Influence Of Eudragit RSPO And Polycaprolactone On The Release Rate And In Vitro Evaluation In The Formulation Of Sustained Release Orlistat Matrix Microparticles. (2022). Journal of Pharmaceutical Negative Results, 1271-1284. https://pnrjournal.com/index.php/home/article/view/2951